-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, V2nNBWt5z5qiCp138t6MFa3MW65OB336hdT2/y10nYw8cxINNrlRaPlBsYTlIllU iU2jRx9Un2lXDk5EAp920Q== 0000874015-07-000026.txt : 20070504 0000874015-07-000026.hdr.sgml : 20070504 20070504185531 ACCESSION NUMBER: 0000874015-07-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070502 FILED AS OF DATE: 20070504 DATE AS OF CHANGE: 20070504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wedel Mark K CENTRAL INDEX KEY: 0001321261 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 07821955 BUSINESS ADDRESS: BUSINESS PHONE: 760-931-9200 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-05-02 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001321261 Wedel Mark K C/O ISIS PHARMACEUTICALS, INC. 1896 RUTHERFORD ROAD CARLSBAD CA 92008 0 1 0 0 VP & Chief Medical Officer Common Stock 2007-05-02 2007-05-02 4 M 0 2000 5.15 A 8603 D Common Stock 2007-05-02 2007-05-02 4 S 0 2000 10.25 D 6603 D Employee Stock Option (right to buy) 5.15 2007-05-02 2007-05-02 4 M 0 2000 0 D 2006-01-01 2008-12-31 Common Stock 2000 8500 D The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3-28-07. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3-28-07. B. Lynne Parshall, Attorney-in-Fact 2007-05-04 -----END PRIVACY-ENHANCED MESSAGE-----